Article
Gut microbiota-derived trimethylamine N-Oxide: a novel target for the treatment of preeclampsia
13 Feb 2024
Abstract excerpt
Pre-eclampsia (PE) is the most common complication of pregnancy and seriously threatens the health and safety of the mother and child. Studies have shown that an imbalance in gut microbiota can affect the progression of PE. Trimethylamine N-oxide (TMAO) is an intestinal microbiota-derived metabolite that is thought to be involved in the occurrence of PE; however, its causal relationship and mechanism remain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
